Showing results (1561-1570 of 1,686) with videos related to
Sort By:
Pageof 169
JMIR Mhealth and Uhealth|October 11, 2024
Smartphone Screen Time Characteristics in People With Suicidal Thoughts: Retrospective Observational Data Analysis StudyMarta Karas, Debbie Huang, Zachary Clement, et al.American Heart Journal|September 26, 2006
Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiativeManesh R Patel, Anita Y Chen, Eric D Peterson, et al.Circulation. Cardiovascular Interventions|April 13, 2018
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting: Trends in Utilization and Propensity-Matched Analysis of In-Hospital OutcomesTanush Gupta, Sahil Khera, Dhaval Kolte, et al.Journal of the American College of Cardiology|April 3, 2020
Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-StudyPhilipp Blanke, Jonathon A Leipsic, Jeffrey J Popma, et al.JACC. Cardiovascular Interventions|April 4, 2024
Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic StenosisKendra J Grubb, John C Lisko, Daniel O'Hair, et al.JAMA Cardiology|June 11, 2025
Institutional Variability in Processes of Care and Outcomes Among Patients With STEMI in the USYasser M Sammour, Safi U Khan, Haoyun Hong, et al.Circulation|May 22, 2002
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluationChristopher K Dyke, Richard C Becker, Neal S Kleiman, et al.American Heart Journal|December 13, 2006
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trialHarvey D White, Neal S Kleiman, Kenneth W Mahaffey, et al.Frontiers in Psychiatry|November 21, 2022
16p13.11 deletion variants associated with neuropsychiatric disorders cause morphological and synaptic changes in induced pluripotent stem cell-derived neuronsElizabeth D Buttermore, Nickesha C Anderson, Pin-Fang Chen, et al.Circulation. Cardiovascular Interventions|June 5, 2024
Impact of Left Atrial Pressure on Outcomes After Mitral Transcatheter Edge-to-Edge RepairYasser M Sammour, Rody G Bou Chaaya, Taha Hatab, et al.Pageof 169